- Record: found
- Abstract: found
- Article: not found
Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers.
Allan 'Ben' Smith
1
,
2 ,
Meera Agar
1
,
3
,
4 ,
Geoff Delaney
1
,
2
,
4 ,
Joseph Descallar
1
,
2 ,
Kelsey Dobell-Brown
3
,
4 ,
Melissa Grand
3
,
4 ,
Jennifer Aung
3
,
4 ,
Pinky Patel
3
,
4 ,
Nasreen Kaadan
1
,
4 ,
Afaf Girgis
1
,
2
Feb 2018
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Clinical trials play a critical role in advancing cancer care, but international research shows that few cancer patients, particularly culturally and linguistically diverse (CALD) patients, participate in trials. This limits generalizability of trial results and increases health disparities. This study aimed to establish rates and correlates of trial participation among CALD patients in South Western Sydney Local Health District (SWSLHD), a highly culturally diverse area.